Trial intelligence / Profile preview

Everolimus and low-dose tacrolimus in renal transplant recipients

NCT00369161Phase 4Completed

Sponsor
Novartis
Start
Jun 2006
Primary completion
Dec 2008
Countries
1
01

Overview

A Phase 4 trial of everolimus in kidney transplant, sponsored by Novartis. Started Jun 2006; status: completed.

02

Drugs

everolimus
03

Conditions

kidney transplant

Beyond the preview

Go deeper on NCT00369161.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00369161.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call